Added a touch more ATTO.
A full position for me but I trade around the edges.
I can't see a specific reason for the sell off but it is up a lot this year and some fund might be looking to take profits.
They report next Wednesday night with the conference call on Thursday morning (Mar 4) at 10 am.
At the very least we should have analyst estimates increased post report as all of the analysts have been restricted because of a debt refinancing since they pre-reported better than expected revenues and EBITDA.
Consensus 2021 EBITDA is $186.5m and they reported an EBITDA range of $50-55m for Q4. That should lift consensus above $200m. At 5% cc revenue growth and 14% margins, 2021E EBITDA would be $217m. They pre-reported margins of 14-14.5% for Q420 so it doesn't seem like a big stretch to assume that for the full year. Each point of margin adds ~$15m to EBITDA.
At $22.50, the company is trading at 4.6x EV/EBITDA on current consensus 2021E EBITDA. If consensus jumps to $217, at 4.6x, the stock would trade at $30.50.
The beauty of leverage and only 16.3m shares outstanding on a fully diluted basis.
I am a valueHODLer here until the strategic sale of the company in 2022 or 2023. Peers trade 8-15x EBITDA. If a sale could be based on 2023E estimates, assuming the same sales growth and a lift of EBITDA margins to 14.5% or the half way point of guidance. We could have a selling price of $90+ based on the low end of the comp range at 8x.
Still a long way to go from here of course but I think it's important to understand the roadmap.